Goldman Sachs has initiated coverage on Bruker Corp (BRKR) with a Sell rating, marking the firm's first assessment of the company's investment potential. This decision underscores the bank's outlook based on its analysis of Bruker’s business dynamics, industry context, and growth prospects.
Headquartered in Billerica, Massachusetts, Bruker Corp specializes in developing and distributing high-performance scientific instruments and analytical solutions. The company operates across several segments, including Bruker Scientific Instruments and Bruker Energy & Supercon Technologies, employing 11,396 full-time staff. As of December 4, 2025, Bruker holds a market capitalization of $7.3 billion, with a trailing twelve-month EPS of -0.14 and a notable dividend yield of 41.8%.
Looking ahead, Bruker is set to report its next earnings on August 3, 2026, with estimates suggesting an EPS of $0.43 and revenue of $832.6 million. Recent earnings performance has shown volatility; for instance, in Q3 2025, the company reported an EPS of $0.45, surpassing estimates by 31.7%. However, in Q2 2025, it fell short of expectations, reporting an EPS of $0.32 against an estimate of $0.43.
Analyst ratings and price targets serve as professional opinions influenced by extensive research and financial models. While they provide valuable insights, they are based on assumptions that may not always hold true. Investors are advised to consider a range of factors, including company fundamentals and market conditions, when making decisions. Analyst perspectives can evolve as new information emerges, and differing opinions on the same company are common among analysts.